These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


550 related items for PubMed ID: 17538551

  • 1. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL, Patel R.
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [Abstract] [Full Text] [Related]

  • 2. [Biofilm--still a problem?].
    Skrlin J.
    Lijec Vjesn; 2010 Aug; 132 Suppl 1():24-6. PubMed ID: 20715715
    [Abstract] [Full Text] [Related]

  • 3. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW.
    Adv Drug Deliv Rev; 2005 Jul 29; 57(10):1539-50. PubMed ID: 15950314
    [Abstract] [Full Text] [Related]

  • 4. Effect of antibacterials on biofilms.
    Aslam S.
    Am J Infect Control; 2008 Dec 29; 36(10):S175.e9-11. PubMed ID: 19084156
    [Abstract] [Full Text] [Related]

  • 5. Survival strategies of infectious biofilms.
    Fux CA, Costerton JW, Stewart PS, Stoodley P.
    Trends Microbiol; 2005 Jan 29; 13(1):34-40. PubMed ID: 15639630
    [Abstract] [Full Text] [Related]

  • 6. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
    Sun F, Qu F, Ling Y, Mao P, Xia P, Chen H, Zhou D.
    Future Microbiol; 2013 Jul 29; 8(7):877-86. PubMed ID: 23841634
    [Abstract] [Full Text] [Related]

  • 7. The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections.
    Rice SA, McDougald D, Kumar N, Kjelleberg S.
    Curr Opin Investig Drugs; 2005 Feb 29; 6(2):178-84. PubMed ID: 15751741
    [Abstract] [Full Text] [Related]

  • 8. [Biofilms, tolerance and antimicrobial resistance].
    Bahar G.
    Mikrobiyol Bul; 2002 Feb 29; 36(3-4):343-51. PubMed ID: 12838670
    [Abstract] [Full Text] [Related]

  • 9. Medical significance and new therapeutical strategies for biofilm associated infections.
    Lazăr V, Chifiriuc MC.
    Roum Arch Microbiol Immunol; 2010 Feb 29; 69(3):125-38. PubMed ID: 21434589
    [Abstract] [Full Text] [Related]

  • 10. New antibiotic agents and approaches to treat biofilm-associated infections.
    Lynch AS, Abbanat D.
    Expert Opin Ther Pat; 2010 Oct 29; 20(10):1373-87. PubMed ID: 20636186
    [Abstract] [Full Text] [Related]

  • 11. Adaptive responses to antimicrobial agents in biofilms.
    Szomolay B, Klapper I, Dockery J, Stewart PS.
    Environ Microbiol; 2005 Aug 29; 7(8):1186-91. PubMed ID: 16011755
    [Abstract] [Full Text] [Related]

  • 12. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.
    Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T.
    Mol Microbiol; 2008 Apr 29; 68(1):223-40. PubMed ID: 18312276
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of bacterial resistance to antimicrobial agents.
    Stratton CW.
    J Med Liban; 2000 Apr 29; 48(4):186-98. PubMed ID: 11214188
    [Abstract] [Full Text] [Related]

  • 14. [Biofilm, foreign bodies and chronic infections].
    Høiby N, Espersen F, Fomsgaard A, Giwercman B, Jensen ET, Johansen HK, Koch C, Kronborg G, Pedersen SS, Pressler T.
    Ugeskr Laeger; 1994 Oct 10; 156(41):5998-6005. PubMed ID: 7992437
    [Abstract] [Full Text] [Related]

  • 15. Biofilms--a neglected antibacterial target?
    Toney JH.
    Curr Opin Investig Drugs; 2007 Aug 10; 8(8):598-9. PubMed ID: 17668361
    [No Abstract] [Full Text] [Related]

  • 16. Biofilm-related disease.
    Del Pozo JL.
    Expert Rev Anti Infect Ther; 2018 Jan 10; 16(1):51-65. PubMed ID: 29235402
    [Abstract] [Full Text] [Related]

  • 17. Biofilms in ear, nose, and throat infections: how important are they?
    Vlastarakos PV, Nikolopoulos TP, Maragoudakis P, Tzagaroulakis A, Ferekidis E.
    Laryngoscope; 2007 Apr 10; 117(4):668-73. PubMed ID: 17415138
    [Abstract] [Full Text] [Related]

  • 18. Effects of persister formation on bacterial response to dosing.
    Cogan NG.
    J Theor Biol; 2006 Feb 07; 238(3):694-703. PubMed ID: 16125727
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
    Ha KR, Psaltis AJ, Butcher AR, Wormald PJ, Tan LW.
    Laryngoscope; 2008 Mar 07; 118(3):535-40. PubMed ID: 18090864
    [Abstract] [Full Text] [Related]

  • 20. Copper resistance of biofilm cells of the plant pathogen Xylella fastidiosa.
    Rodrigues CM, Takita MA, Coletta-Filho HD, Olivato JC, Caserta R, Machado MA, de Souza AA.
    Appl Microbiol Biotechnol; 2008 Jan 07; 77(5):1145-57. PubMed ID: 17992525
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.